Skip to main content
Top
Published in: BMC Infectious Diseases 1/2019

Open Access 01-12-2019 | Aortic Valve Replacement | Case report

Infective endocarditis caused by Capnocytophaga canimorsus; a case report

Authors: Jun Sakai, Kazuhito Imanaka, Masahiro Kodana, Kana Ohgane, Susumu Sekine, Kei Yamamoto, Yusuke Nishida, Toru Kawamura, Takahiro Matsuoka, Shigefumi Maesaki, Hideaki Oka, Hideaki Ohno

Published in: BMC Infectious Diseases | Issue 1/2019

Login to get access

Abstract

Background

Capnocytophaga canimorsus is a gram-negative bacterium and an oral commensal in dogs and cats, but occasionally causes serious infections in humans. Septicemia is one of the most fulminant forms, but diagnosis of C. canimorsus infection is often difficult mainly because of its very slow growth. C. canimorsus infective endocarditis (IE) is rare and is poorly understood. Since quite a few strains produce β-lactamase, antimicrobial susceptibility is pivotal information for adequate treatment. We herein report a case with C. canimorsus IE and the results of drug susceptibility test.

Case presentation

A 46-year-old man had a dog bite in his left hand 3 months previously. The patient was referred to our hospital for fever (body temperature > 38 °C), visual disturbance, and dyspnea. Echocardiography showed aortic valve regurgitation and vegetation on the leaflets. IE was diagnosed, and we initially administered cefazolin and gentamycin assuming frequently encountered microorganisms and the patient underwent aortic valve replacement. C. canimorsus was detected in the aortic valve lesion and blood cultures. It was also identified by 16S ribosome DNA sequencing. Ceftriaxone were started and continued because disk diffusion test revealed the isolate was negative for β-lactamase and this case had cerebral symptoms. The patient successfully completed antibiotic treatment following surgery.

Conclusions

We diagnosed C. canimorsus sepsis and IE by extended-period blood cultures and 16S ribosome DNA sequencing by polymerase chain reaction, and successfully identified its drug susceptibility.
Literature
1.
go back to reference Bobo RA, Newton EJ. A previously undescribed gram-negative bacillus causing septicemia and meningitis. Am J Clin Pathol. 1976;65:564–9.CrossRef Bobo RA, Newton EJ. A previously undescribed gram-negative bacillus causing septicemia and meningitis. Am J Clin Pathol. 1976;65:564–9.CrossRef
2.
go back to reference Wilson W, Taubert KA, Gewitz M, Lockhart PB, Baddour LM, Levison M, et al. Prevention of infective endocarditis: a guideline from the American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee, Council on Cardiovascular Disease in the Young, and the council on clinical cardiology, council on cardiovascular surgery and anesthesia, and the quality of care and outcomes research interdisciplinary working group. Circulation. 2007;116:1736–54.CrossRef Wilson W, Taubert KA, Gewitz M, Lockhart PB, Baddour LM, Levison M, et al. Prevention of infective endocarditis: a guideline from the American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee, Council on Cardiovascular Disease in the Young, and the council on clinical cardiology, council on cardiovascular surgery and anesthesia, and the quality of care and outcomes research interdisciplinary working group. Circulation. 2007;116:1736–54.CrossRef
3.
go back to reference Janda JM, Graves MH, Lindquist D, Probert WS. Diagnosing Capnocytophaga canimorsus infections. Emerg Infect Dis. 2006;12:340–2.CrossRef Janda JM, Graves MH, Lindquist D, Probert WS. Diagnosing Capnocytophaga canimorsus infections. Emerg Infect Dis. 2006;12:340–2.CrossRef
4.
go back to reference Sandoe JA. Capnocytophaga canimorsus endocarditis. J Med Microbiol. 2004;53:245–8.CrossRef Sandoe JA. Capnocytophaga canimorsus endocarditis. J Med Microbiol. 2004;53:245–8.CrossRef
5.
go back to reference Frigiola A, Badia T, Lovato R, et al. Infective endocarditis due to Capnocytophaga canimorsus. Ital Heart J. 2003;4:725–7.PubMed Frigiola A, Badia T, Lovato R, et al. Infective endocarditis due to Capnocytophaga canimorsus. Ital Heart J. 2003;4:725–7.PubMed
6.
go back to reference Wareham DW, Michael JS, Warwick S, Whitlock P, Wood A, Das SS. The dangers of dog bites. J Clin Pathol. 2007;60:328–9.CrossRef Wareham DW, Michael JS, Warwick S, Whitlock P, Wood A, Das SS. The dangers of dog bites. J Clin Pathol. 2007;60:328–9.CrossRef
7.
go back to reference Hayani O, Higginson LA, Toye B, Burwash IG. Man’s best friend? Infective endocarditis due to Capnocytophaga canimorsus. Can J Cardiol. 2009;25:e130–2.CrossRef Hayani O, Higginson LA, Toye B, Burwash IG. Man’s best friend? Infective endocarditis due to Capnocytophaga canimorsus. Can J Cardiol. 2009;25:e130–2.CrossRef
8.
go back to reference Coutance G, Labombarda F, Pellissier A, Legallois D, Hamon M, Bachelet C, et al. Capnocytophaga canimorsus endocarditis with root abscess in a patient with a bicuspid aortic valve. Heart Int. 2009;4(1):e5.CrossRef Coutance G, Labombarda F, Pellissier A, Legallois D, Hamon M, Bachelet C, et al. Capnocytophaga canimorsus endocarditis with root abscess in a patient with a bicuspid aortic valve. Heart Int. 2009;4(1):e5.CrossRef
9.
go back to reference Jalava-Karvinen P, Grönroos JO, Tuunanen H, Kemppainen J, Oksi J, Hohenthal U. Capnocytophaga canimorsus: a rare case of conservatively treated prosthetic valve endocarditis. APMIS. 2018;126:453–6.CrossRef Jalava-Karvinen P, Grönroos JO, Tuunanen H, Kemppainen J, Oksi J, Hohenthal U. Capnocytophaga canimorsus: a rare case of conservatively treated prosthetic valve endocarditis. APMIS. 2018;126:453–6.CrossRef
10.
go back to reference Barry M. Double Native Valve Infective Endocarditis due to Capnocytophaga canimorsus: First Reported Case Caused by a Lion Bite. Case Rep Infect Dis. 2018;2018:4821939.PubMedPubMedCentral Barry M. Double Native Valve Infective Endocarditis due to Capnocytophaga canimorsus: First Reported Case Caused by a Lion Bite. Case Rep Infect Dis. 2018;2018:4821939.PubMedPubMedCentral
11.
go back to reference Dolieslager SM, Riggio MP, Lennon A, Lappin DF, Johnston N, Taylor D, Bennett D. Identification of bacteria associated with feline chronic gingivostomatitis using culture-dependent and culture-independent methods. Vet Microbiol. 2011;148:93–8.CrossRef Dolieslager SM, Riggio MP, Lennon A, Lappin DF, Johnston N, Taylor D, Bennett D. Identification of bacteria associated with feline chronic gingivostomatitis using culture-dependent and culture-independent methods. Vet Microbiol. 2011;148:93–8.CrossRef
12.
go back to reference Gross EL, Leys EJ, Gasparovich SR, Firestone ND, Schwartzbaum JA, Janies DA, Asnani K, Griffen AL. Bacterial 16S sequence analysis of severe caries in young permanent teeth. J Clin Microbiol. 2010;48:4121–8.CrossRef Gross EL, Leys EJ, Gasparovich SR, Firestone ND, Schwartzbaum JA, Janies DA, Asnani K, Griffen AL. Bacterial 16S sequence analysis of severe caries in young permanent teeth. J Clin Microbiol. 2010;48:4121–8.CrossRef
13.
go back to reference Jolivet-Gougeon A, Sixou JL, Tamanai-Shacoori Z, Bonnaure-Mallet M. Antimicrobial treatment of Capnocytophaga infections. Int J Antimicrob Agents. 2007;29:367–73.CrossRef Jolivet-Gougeon A, Sixou JL, Tamanai-Shacoori Z, Bonnaure-Mallet M. Antimicrobial treatment of Capnocytophaga infections. Int J Antimicrob Agents. 2007;29:367–73.CrossRef
14.
go back to reference Foweraker JE, Hawkey PM, Heritage J, Van Landuyt HW. Novel β-lactamase from Capnocytophaga sp. Antimicrob Agents Chemother. 1990;34:1501–4.CrossRef Foweraker JE, Hawkey PM, Heritage J, Van Landuyt HW. Novel β-lactamase from Capnocytophaga sp. Antimicrob Agents Chemother. 1990;34:1501–4.CrossRef
15.
go back to reference Roscoe DL, Zemcov SJ, Thornber D, Wise R, Clarke AM. Antimicrobial susceptibilities and β-lactamase characterization of Capnocytophaga species. Antimicrob Agents Chemother. 1992;36:2197–200.CrossRef Roscoe DL, Zemcov SJ, Thornber D, Wise R, Clarke AM. Antimicrobial susceptibilities and β-lactamase characterization of Capnocytophaga species. Antimicrob Agents Chemother. 1992;36:2197–200.CrossRef
16.
go back to reference Jolivet-Gougeon A, Buffet A, Dupuy C, Sixou JL, Bonnaure-Mallet M, David S, Cormier M. In vitro susceptibilities of Capnocytophaga to β-lactam antibiotics and β-lactamase inhibitors. Antimicrob Agents Chemother. 2000;44:3186–8.CrossRef Jolivet-Gougeon A, Buffet A, Dupuy C, Sixou JL, Bonnaure-Mallet M, David S, Cormier M. In vitro susceptibilities of Capnocytophaga to β-lactam antibiotics and β-lactamase inhibitors. Antimicrob Agents Chemother. 2000;44:3186–8.CrossRef
Metadata
Title
Infective endocarditis caused by Capnocytophaga canimorsus; a case report
Authors
Jun Sakai
Kazuhito Imanaka
Masahiro Kodana
Kana Ohgane
Susumu Sekine
Kei Yamamoto
Yusuke Nishida
Toru Kawamura
Takahiro Matsuoka
Shigefumi Maesaki
Hideaki Oka
Hideaki Ohno
Publication date
01-12-2019
Publisher
BioMed Central
Published in
BMC Infectious Diseases / Issue 1/2019
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/s12879-019-4492-3

Other articles of this Issue 1/2019

BMC Infectious Diseases 1/2019 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.